Clomipramine is not an SSRI. It belongs to an older class of antidepressants called tricyclic antidepressants (TCAs), which were developed decades before SSRIs came to market. The confusion is understandable, though, because clomipramine acts on serotonin more powerfully than most other tricyclics, and it treats many of the same conditions that SSRIs do, particularly obsessive-compulsive disorder (OCD).
Why Clomipramine Gets Confused With SSRIs
Clomipramine is sometimes called the most “serotonergic” tricyclic antidepressant. Like SSRIs, it blocks the reuptake of serotonin, increasing serotonin levels in the brain. This shared mechanism is why both clomipramine and SSRIs work well for OCD and anxiety disorders.
But clomipramine doesn’t stop there. It also blocks the reuptake of norepinephrine, another brain chemical involved in mood and alertness. On top of that, it binds to histamine receptors and acetylcholine receptors, which SSRIs largely leave alone. This broader activity is what makes clomipramine a tricyclic rather than a selective serotonin reuptake inhibitor. The “selective” in SSRI means those drugs primarily target serotonin and mostly avoid other receptor systems. Clomipramine is anything but selective.
Once your body metabolizes clomipramine, it produces an active breakdown product called desmethylclomipramine. This metabolite shifts the drug’s activity even further toward norepinephrine reuptake inhibition, giving the medication a dual action that no SSRI provides.
How TCAs Differ From SSRIs in Practice
The practical difference between clomipramine and an SSRI comes down to side effects. Because clomipramine interacts with histamine and acetylcholine receptors, it produces a wider range of unwanted effects. Dry mouth, constipation, blurred vision, drowsiness, and weight gain are all common with tricyclics and stem directly from these extra receptor interactions. SSRIs can cause some of these too, but generally to a lesser degree.
Research comparing anticholinergic effects (the dry mouth, constipation, and cognitive fog side of things) found that clomipramine’s ratio of anticholinergic activity to antidepressant activity was notably higher than that of SSRIs like fluvoxamine. In animal models, clomipramine produced anticholinergic effects at doses below its therapeutic range, while fluvoxamine required doses more than three times its effective antidepressant level to produce similar effects.
Tricyclics also carry risks that SSRIs generally don’t, including cardiac rhythm changes and a lower seizure threshold. An overdose of a tricyclic like clomipramine is far more dangerous than an SSRI overdose, which is one reason SSRIs gradually replaced TCAs as first-line treatments for depression and anxiety starting in the late 1980s.
What Clomipramine Is Used For
The only FDA-approved use for clomipramine is treating OCD in patients aged 10 and older. It was actually the first medication specifically approved for OCD, and it remains one of the most effective options for the condition. A 2024 meta-analysis published in BMJ Mental Health found that clomipramine studies consistently showed higher effect sizes than SSRI studies for OCD, even after correcting for study quality and potential bias.
Beyond OCD, clomipramine is prescribed off-label for a wide range of conditions:
- Depression and treatment-resistant depression
- Anxiety and panic disorder
- Chronic and neuropathic pain
- Body dysmorphic disorder
- Insomnia
- Premature ejaculation
- Cataplexy (sudden muscle weakness episodes linked to narcolepsy)
- Trichotillomania (compulsive hair pulling)
- Bedwetting in children
Many of these overlap with SSRI uses, which further explains why people assume clomipramine belongs to the same class.
Clomipramine vs. SSRIs for OCD
Despite SSRIs being the standard first-line treatment for OCD today, clomipramine often outperforms them. The BMJ Mental Health meta-analysis found that clomipramine’s advantage over placebo was statistically larger than the advantage seen with SSRIs, and this held up even when researchers accounted for methodological differences between older and newer studies.
So why aren’t more people with OCD started on clomipramine? The side effect profile is the main reason. Most clinicians try one or more SSRIs before turning to clomipramine, reserving it for cases where SSRIs haven’t worked well enough. The tolerability tradeoff, not the efficacy, is what keeps clomipramine in a second-line role for most patients.
How Clomipramine Is Taken
Treatment typically starts at 25 mg per day and is gradually increased to around 100 mg over the first two weeks. After that initial ramp-up, the dose can be raised further over several weeks up to a maximum of 250 mg daily. This slow titration helps minimize side effects, especially sedation and dizziness, which tend to be worst in the early weeks before the body adjusts.
The gradual dose increase is more drawn out than what most SSRIs require, and stopping clomipramine also needs to be done slowly. Abruptly discontinuing any tricyclic can cause withdrawal symptoms including nausea, headache, and irritability.
The Bottom Line on Classification
Clomipramine is a tricyclic antidepressant with unusually strong serotonin activity. It shares a key mechanism with SSRIs (boosting serotonin) but adds norepinephrine reuptake inhibition and multiple receptor interactions that SSRIs avoid. This makes it more effective than SSRIs for some conditions, particularly OCD, but also gives it a heavier side effect burden. If you see clomipramine described as “SSRI-like,” that’s a reference to its serotonin potency, not its actual drug class.